الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 173 |  |  |
| | | from | 173 | | |
Abstract
Summary and conclusion
Transarterial chemoembolization {TACE} is an optimal
treatment for HCC patients with unresectable, intermediate stage
hepatocellular carcinoma {HCC} without significant hepatic
synthetic dysfunction.
TACE may be associated with many injurious complications
although it may be associated with increased survival in some
patients
TACE produces elevation in portal blood flow and increased
intravariceal pressure and in rare instances may precipitate
varecial bleeding in patients with coexisting portal hypertension.
This study was aimed to detect TACE complications with
especial emphasis in changes in varicial size after treatment.
Methods: our study was conducted on 77 naïve
hepatocellular carcinoma patients with small sized esophageal
varices with no history of upper gastrointestinal bleeding or prophylactic beta – blocker treatment.
These HCC patients were diagnosed according to the
American association for the study of liver disease 2010 {hepatic
focal lesion with CT or MRI criteria of HCC wash in arterial
phase and wash out in portovenous-delayed phases}.
These patients were conducted on liver functions tests, renal
functions tests , INR , CBC and AFP and viral markers .These patients were treated with TACE according Barcelona –Clinic